BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22969761)

  • 21. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
    Kozako T; Arima N; Toji S; Masamoto I; Akimoto M; Hamada H; Che XF; Fujiwara H; Matsushita K; Tokunaga M; Haraguchi K; Uozumi K; Suzuki S; Takezaki T; Sonoda S
    J Immunol; 2006 Oct; 177(8):5718-26. PubMed ID: 17015761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells.
    Furukawa Y; Osame M; Kubota R; Tara M; Yoshida M
    Blood; 1995 Apr; 85(7):1865-70. PubMed ID: 7703492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.
    Enose-Akahata Y; Vellucci A; Jacobson S
    Front Microbiol; 2017; 8():2563. PubMed ID: 29312243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.
    Mori N; Sato H; Hayashibara T; Senba M; Hayashi T; Yamada Y; Kamihira S; Ikeda S; Yamasaki Y; Morikawa S; Tomonaga M; Geleziunas R; Yamamoto N
    Blood; 2002 Feb; 99(4):1341-9. PubMed ID: 11830485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.
    Yasunaga Ji ; Sakai T; Nosaka K; Etoh Ki ; Tamiya S; Koga S; Mita S; Uchino M; Mitsuya H; Matsuoka M
    Blood; 2001 May; 97(10):3177-83. PubMed ID: 11342446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
    Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
    PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
    Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
    McGinn TM; Wei Q; Stallworth J; Fultz PN
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Saito M; Sejima H; Naito T; Ushirogawa H; Matsuzaki T; Matsuura E; Tanaka Y; Nakamura T; Takashima H
    Virol J; 2017 Dec; 14(1):234. PubMed ID: 29202792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
    Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
    PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.
    Watanabe T; Yamaguchi K; Takatsuki K; Osame M; Yoshida M
    J Exp Med; 1990 Sep; 172(3):759-65. PubMed ID: 2388034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.